Search

Search Constraints

You searched for: Author/Creator Haller, Daniel G.

Search Results

1. A Phase II Study of Celecoxib With Irinotecan, 5-Fluorouracil, and Leucovorin in Patients With Previously Untreated Advanced or Metastatic Colorectal Cancer. (December 2018)

2. Adjuvant therapy for resected colon cancer 2017, including the IDEA analysis. Issue 4 (3rd April 2018)

3. Intergroup Randomized Phase III Study of Postoperative Oxaliplatin, 5‐Fluorouracil, and Leucovorin Versus Oxaliplatin, 5‐Fluorouracil, Leucovorin, and Bevacizumab for Patients with Stage II or III Rectal Cancer Receiving Preoperative Chemoradiation: A Trial of the ECOG‐ACRIN Research Group (E5204). (18th December 2019)

4. Pharmacogenetic study in gastric cancer patients treated with adjuvant fluorouracil/leucovorin or epirubicin/cisplatin/fluorouracil before and after chemoradiation on CALGB 80101 (Alliance). Issue 9 (December 2021)

5. Prognostic Impact of Early Treatment and Oxaliplatin Discontinuation in Patients With Stage III Colon Cancer: An ACCENT/IDEA Pooled Analysis of 11 Adjuvant Trials. Issue 4 (1st February 2023)

6. Targeted therapy for metastatic colorectal cancer. Issue 10 (3rd October 2018)

7. Treatment sequence of synchronously (liver) metastasized colon cancer. Issue 10 (October 2016)

8. Update on optimal treatment for metastatic colorectal cancer from the AGITG expert meeting: ESMO congress 2019. Issue 4 (2nd April 2020)

9. Validity of Adjuvant! Online in older patients with stage III colon cancer based on 2967 patients from the ACCENT database. Issue 6 (November 2016)